| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.05 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |